A randomized clinical trial highlights the efficacy of liposomal iron therapy in treating iron deficiency anemia among pediatric chronic kidney disease (CKD) patients. The treatment significantly improved anemia outcomes compared to standard care, promising a safer and more effective approach to address this common comorbidity in children with CKD and potentially enhancing quality of life and reducing transfusion needs.